These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1645830)

  • 21. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
    Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA
    Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is flumazenil an alternative for the treatment of hepatic encephalopathy?
    Reyes D; Barrera F
    Medwave; 2017 Dec; 17(9):e7113. PubMed ID: 29286356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
    Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M
    Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Flumazenil in the treatment of hepatic encephalopathy].
    Pintanel T; Font MM; García-Guasch R
    Med Clin (Barc); 1990 Jun; 95(4):157. PubMed ID: 2250539
    [No Abstract]   [Full Text] [Related]  

  • 25. Improvement of hepatic encephalopathy treated with flumazenil.
    Grimm G; Ferenci P; Katzenschlager R; Madl C; Schneeweiss B; Laggner AN; Lenz K; Gangl A
    Lancet; 1988 Dec; 2(8625):1392-4. PubMed ID: 2904525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
    Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G
    Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of hepatic encephalopathy with flumazenil].
    Elkjaer JM; Jensen TU; Emborg J
    Ugeskr Laeger; 2000 Aug; 162(35):4681-4. PubMed ID: 10986901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.
    Meier R; Gyr K
    Eur J Anaesthesiol Suppl; 1988; 2():139-46. PubMed ID: 2842130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flumazenil.
    Cone AM; Stott SA
    Br J Hosp Med; 1994 Apr 6-19; 51(7):346-8. PubMed ID: 8081564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persisting benzodiazepine metabolites responsible for the reaction to the benzodiazepine antagonist flumazenil in patients with hepatic encephalopathy.
    Meier R; Gyr K; Scholer A
    Gastroenterology; 1991 Jul; 101(1):274-5. PubMed ID: 2044919
    [No Abstract]   [Full Text] [Related]  

  • 31. Flumazenil in the treatment of hepatic encephalopathy.
    Howard CD; Seifert CF
    Ann Pharmacother; 1993 Jan; 27(1):46-8. PubMed ID: 8431621
    [No Abstract]   [Full Text] [Related]  

  • 32. Flumazenil and hepatic encephalopathy.
    Amaral OB; Quevedo J; Walz R; Kapczinski F
    Hepatology; 1999 Apr; 29(4):1338-9. PubMed ID: 10336339
    [No Abstract]   [Full Text] [Related]  

  • 33. Flumazenil in the treatment of portal systemic encephalopathy--an overview.
    Gyr K; Meier R
    Intensive Care Med; 1991; 17 Suppl 1():S39-42. PubMed ID: 1774410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The quantitative electroencephalogram in a case of acute hepatic encephalopathy treated with flumazenil].
    Frenkel AL; Hermant JL; Blaise M; Volter F; Pourriat JL
    Cah Anesthesiol; 1991; 39(1):61-2. PubMed ID: 2054699
    [No Abstract]   [Full Text] [Related]  

  • 35. Flumazenil and hepatic encephalopathy.
    Klotz U; Walker S
    Lancet; 1989 Jan; 1(8630):155-6. PubMed ID: 2563065
    [No Abstract]   [Full Text] [Related]  

  • 36. Benzodiazepine receptor ligands and hepatic encephalopathy: further unfolding of the GABA story.
    Jones EA
    Hepatology; 1991 Dec; 14(6):1286-90. PubMed ID: 1660022
    [No Abstract]   [Full Text] [Related]  

  • 37. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands.
    Basile AS; Jones EA; Skolnick P
    Pharmacol Rev; 1991 Mar; 43(1):27-71. PubMed ID: 1674609
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of flumazenil in the treatment of hepatic encephalopathy secondary to acute liver failure. A report of 2 cases].
    Díaz de León-Ponce M; Eid-Lidt G; Castañón-González JA; Deseaño-Estudillo JL; Reyes B
    Gac Med Mex; 1993; 129(5):347-50. PubMed ID: 7926421
    [No Abstract]   [Full Text] [Related]  

  • 39. Endozepines in recurrent stupor.
    Cortelli P; Avallone R; Baraldi M; Zeneroli ML; Mandrioli J; Corsi L; Riva R; Tinuper P; Lugaresi E; Baruzzi A; Montagna P
    Sleep Med Rev; 2005 Dec; 9(6):477-87. PubMed ID: 16233983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis.
    Ozyilkan E; Kahraman H; Onar M; Kesim G; Arik Z
    East Afr Med J; 1997 Apr; 74(4):210-2. PubMed ID: 9299818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.